Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1976 1
1977 2
1978 1
1979 6
1980 14
1981 15
1982 5
1983 4
1984 1
1985 2
1986 4
1987 2
1988 5
1989 2
1990 2
1991 5
1993 1
1994 4
1995 6
1996 9
1997 12
1998 5
1999 3
2000 20
2001 15
2002 7
2003 15
2004 11
2005 12
2006 13
2007 13
2008 11
2009 13
2010 12
2011 7
2012 9
2013 10
2014 15
2015 16
2016 9
2017 11
2018 13
2019 13
2020 9
2021 6
2022 4
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

347 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Pregnanolone Glutamate and Its Metabolites on GABAA and NMDA Receptors and Zebrafish Behavior.
Abramova V, Leal Alvarado V, Hill M, Smejkalova T, Maly M, Vales K, Dittert I, Bozikova P, Kysilov B, Hrcka Krausova B, Vyklicky V, Balik A, Fili K, Korinek M, Chodounska H, Kudova E, Ciz D, Martinovic J, Cerny J, Bartunek P, Vyklicky L. Abramova V, et al. ACS Chem Neurosci. 2023 May 17;14(10):1870-1883. doi: 10.1021/acschemneuro.3c00131. Epub 2023 May 1. ACS Chem Neurosci. 2023. PMID: 37126803 Free PMC article.
Ganaxolone: First Approval.
Lamb YN. Lamb YN. Drugs. 2022 Jun;82(8):933-940. doi: 10.1007/s40265-022-01724-0. Drugs. 2022. PMID: 35596878 Review.
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial.
Knight EMP, Amin S, Bahi-Buisson N, Benke TA, Cross JH, Demarest ST, Olson HE, Specchio N, Fleming TR, Aimetti AA, Gasior M, Devinsky O; Marigold Trial Group. Knight EMP, et al. Lancet Neurol. 2022 May;21(5):417-427. doi: 10.1016/S1474-4422(22)00077-1. Lancet Neurol. 2022. PMID: 35429480 Clinical Trial.
347 results
-